Evidence map›Paper›PMID 29150625›Full record

ArticleScientific reports2017

Porphyromonas gingivalis lipopolysaccharides act exclusively through TLR4 with a resilience between mouse and human.

Brice Nativel, David Couret, Pierre Giraud, Olivier Meilhac, Christian Lefebvre d'Hellencourt, Wildriss Viranaïcken, Christine Robert Da Silva

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

94 citing papers in PubMed, 132 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Candidalysin InhibitsInternational journal of molecular sciences · 2026
    Article
  5. Article
  6. Article
  7. Modulation of microbial community and metabolism throughJournal of animal science and technology · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Anti-Inflammatory, Antioxidant, and Reparative Effects ofAntioxidants (Basel, Switzerland) · 2025
    Article
  12. Article
  13. Noradrenaline Synergistically EnhancesInternational journal of molecular sciences · 2025
    Article
  14. Neutrophils: emerging perspectives on the pathogenesis of oral mucosal diseases.Frontiers in cellular and infection microbiology · 2025
    Review
  15. Recognition ofJournal of oral microbiology · 2025
    Article
  16. Article
  17. Article
  18. Frontiers in immunology · 2025
    Review
  19. Article
  20. Synergistic effects ofFrontiers in cellular and infection microbiology · 2025
    Article

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Brice NativelUniversité de La Réunion, INSERM, UMR 1188 Diabète athérothombose Thérapies Réunion Océan Indien (DéTROI), Saint-Denis de La Réunion, France.
David CouretUniversité de La Réunion, INSERM, UMR 1188 Diabète athérothombose Thérapies Réunion Océan Indien (DéTROI), Saint-Denis de La Réunion, France.
Pierre GiraudUniversité de La Réunion, INSERM, UMR 1188 Diabète athérothombose Thérapies Réunion Océan Indien (DéTROI), Saint-Denis de La Réunion, France.
Olivier MeilhacUniversité de La Réunion, INSERM, UMR 1188 Diabète athérothombose Thérapies Réunion Océan Indien (DéTROI), Saint-Denis de La Réunion, France.
Christian Lefebvre d'HellencourtUniversité de La Réunion, INSERM, UMR 1188 Diabète athérothombose Thérapies Réunion Océan Indien (DéTROI), Saint-Denis de La Réunion, France.
Wildriss ViranaïckenUniversité de La Réunion, CNRS UMR9192, INSERM U1187, IRD UMR249, Unité Mixte Processus Infectieux en Milieu Insulaire Tropical (PIMIT), Plateforme Technologique CYROI, Sainte-Clotilde, La Réunion, France. viranaicken.wildriss@univ-reunion.fr.
Christine Robert Da SilvaUniversité de La Réunion, INSERM, UMR 1188 Diabète athérothombose Thérapies Réunion Océan Indien (DéTROI), Saint-Denis de La Réunion, France. christine.robert@univ-reunion.fr.
Écologie Marine Tropicale des Océans Pacifique et Indien · RECentre Hospitalier Universitaire de La Réunion · FRInserm · FRProcessus Infectieux en Milieu Insulaire Tropical · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Porphyromonas gingivalis is a key bacterium in chronic periodontitis, which is associated with several chronic inflammatory diseases. Lipopolysaccharides from P. gingivalis (Pg LPS) can activate multiple cell types via the production of pro-inflammatory cytokines. The receptors for Pg LPS have initially been reported as TLR2, contrasting with the well-studied TLR4 receptor for E. coli LPS; this observation remains controversial since synthetic Pg lipid A activates TLR4 but not TLR2. Despite this observation, the dogma of Pg LPS-mediated TLR2 activation remains the basis of many hypotheses and result interpretations. In the present work, we aimed at determining whether TLR4 or TLR2, or both, mediate Pg LPS pro-inflammatory activity using Pg LPS with different grades of purity, instead of synthetic lipid A from Pg LPS. Here we show that Pg LPS 1) acts exclusively through TLR4, and 2) are differently recognized by mouse and human TLR4 both in vitro and in vivo. Taken together, our results suggest that Pg LPS activity is mediated exclusively through TLR4 and only weakly induces proinflammatory cytokine secretion in mouse models. Caution should be taken when extrapolating data from mouse systems exposed to Pg or Pg LPS to humans.

Indexed as

AdipocytesAnimalsCell LineCytokinesEndothelial CellsHumansInflammationLipopolysaccharidesMiceMice, Inbred C57BLMicrogliaModels, BiologicalNF-kappa BPorphyromonas gingivalisRAW 264.7 CellsSpectrometry, Mass, Electrospray IonizationCytokinesLipopolysaccharidesNF-kappa BToll-Like Receptor 2Toll-Like Receptor 4Transcription Factor AP-1

Identifiers

PMID29150625
PMCPMC5693985
OpenAlexW2768227814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.